article_snippet.sent: A vaccine has been developed to help prevent the recurrence of prostate cancer (cells pictured)
article_snippet.sent: A vaccine has been developed to help prevent the recurrence of prostate cancer, and potentially other cancers.
article_snippet.sent: A vaccine's designed to teach the immune system to recognise compounds found in prostate cancer cells and is being given to men who have already been treated for prostate cancer.
article_snippet.sent: A vaccine is made from pieces of a protein called TARP that's found in about 95 per cent of prostate cancers.
article_snippet.sent: The thinking is that A vaccine will prime the immune system so that the immune system creates antibodies when the immune system detects TARP-related cancers.
article_snippet.sent: Then, should the cancer reappear, A vaccine will be dispatched to attack prostate cancer cells.
article_snippet.sent: A vaccine, along with other immune cells, can then destroy cancer cells without harming non-cancer cells, so minimising side-effects.
article_snippet.sent: Researchers at the U.S. National Cancer Institute are using A vaccine on 70 men who have been treated for Prostate cancer, but whose PSA is rising again (posed by model)
article_snippet.sent: Researchers at the U.S. National Cancer Institute are using A vaccine on 70 men who have been treated for Prostate cancer, but whose PSA PSA is rising again.
highlights_snippet.sent: Vaccine is made from pieces of a protein called TARP .
  